0001225208-12-016952.txt : 20120801 0001225208-12-016952.hdr.sgml : 20120801 20120801115312 ACCESSION NUMBER: 0001225208-12-016952 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120730 FILED AS OF DATE: 20120801 DATE AS OF CHANGE: 20120801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOUTHWELL DAVID P CENTRAL INDEX KEY: 0001251553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14169 FILM NUMBER: 12999092 MAIL ADDRESS: STREET 1: 350 MAIN ST CITY: CONCORD STATE: MA ZIP: 01742 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMAN GENOME SCIENCES INC CENTRAL INDEX KEY: 0000901219 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223178468 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850-3338 BUSINESS PHONE: 3013098504 MAIL ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc4.xml X0306 4 2012-07-30 1 0000901219 HUMAN GENOME SCIENCES INC HGSI 0001251553 SOUTHWELL DAVID P 14200 SHADY GROVE ROAD ROCKVILLE MD 20850 1 Chief Financial Officer Common Stock 2012-07-30 4 U 0 90835.0000 14.2500 D 0.0000 D Employee Stock Option - Right to Buy 8.2300 2012-07-30 4 D 0 108000.0000 14.2500 D 2022-03-10 Common Stock 108000.0000 0.0000 D This option was cancelled in the tender offer that expired on July 27, 2012 in exchange for a cash payment of $650,160.00, representing the difference between the exercise price of the option and the offer price ($14.25 per share) pursuant to the Merger Agreement between the issuer and GlaxoSmithKline plc.These options vested automatically upon consummation of the tender offer on July 30, 2012. /s/ David Southwell 2012-07-30